Q3 Asset Management’s Eli Lilly LLY Stock Holding History

Q3 Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,408	Closed	-$1.99M	–	53
2023 Q4	$1.99M	Sell	3,408 -181	-5%	-$106K	0.5%	23
2023 Q3	$1.93M	Buy	+3,589	New	+$1.85M	0.77%	17
2023 Q1	–	Sell	-2,957	Closed	-$1.08M	–	57
2022 Q4	$1.08M	Buy	+2,957	New	+$1.05M	0.73%	28
2021 Q4	–	Sell	-2,717	Closed	-$627K	–	52
2021 Q3	$627K	Buy	+2,717	New	+$671K	0.3%	35

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Q3 Asset Management's LLY Position: Q1 2024 in Review

Q3 Asset Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 3,408 shares — an estimated $1.99M sold.

Q3 Asset Management first reported a position in LLY in Q3 2021 and held it in 4 quarters. The position peaked at $1.99M in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

Q3 Asset Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
Q3 Asset Management sold 3,408 Eli Lilly shares in Q1 2024, an estimated $1.99M.
Q3 Asset Management first reported a position in Eli Lilly in Q3 2021 and held it in 4 quarters.
Q3 Asset Management's Eli Lilly position peaked at $1.99M in Q4 2023.
3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Q3 Asset Management's 13F filing for Q1 2024, filed 25 Apr 2024.